Ciprofloxacin vs Rituximab

Ciprofloxacin vs Rituximab: Overview

This comparison examines the pharmacological differences between Ciprofloxacin and Rituximab.

Mechanism of Action

Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Ciprofloxacin — 4 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Ciprofloxacin — C17H18FN3O3.

Molecular Weight: Ciprofloxacin — 331.3460 g/mol.

Type: Ciprofloxacin — Small molecule; Rituximab — Antibody.